Medexus Pharmaceuticals, Inc. (MDP) is a leading innovative and rare disease pharmaceutical company dedicated to improving the quality of life for patients. With a focus on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases, we provide market-leading prescription and over-the-counter brands that greatly enhance quality of life and promote a healthy lifestyle.

At Medexus Pharmaceuticals, our mission is to provide the best healthcare products to healthcare professionals and patients. We prioritize Quality, Innovation, Customer Service, and Collaboration in everything we do. Our commitment to innovation drives us to continuously license and acquire new products and solutions to address the essential needs of consumers, patients, and healthcare partners.

Our strong North American commercial platform is divided into two segments: Medexus Pharma Canada and Medexus Pharma USA. This allows us to effectively reach patients and healthcare professionals across the continent. With a focus on trust, transparency, and the highest level of product quality, we strive to build strong relationships with our customers and partners.

Our experienced leadership team is dedicated to driving organic growth by leveraging our existing product portfolio, supporting recent and future product launches, acquiring new products, and further developing existing molecules to better meet the needs of patients. For the latest financial information, including our fiscal year 2023 results, please refer to our official documents available in PDF and audio formats. Discover the Medexus Pharmaceuticals difference and how we're improving quality of life, one prescription at a time